Specialist Appointed to Strengthen Team

RNS Number : 1158V
FastForward Innovations Limited
12 April 2021
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

12 April 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")

 

Specialist Appointed to Strengthen Investment Team

 

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce that it has appointed Mr. Alfredo Pascual as Vice President of Investment Analysis effective 1 April 2021.

 

In this role, Alfredo's focus will be on sourcing and evaluating investment opportunities in the burgeoning European medical cannabis industry as well as supporting the growth of FastForward's portfolio companies in the sector.

 

Having worked in the cannabis space since the end of 2016, Alfredo is a well-known name in the sector across global markets.  Alfredo most recently worked as International Analyst at Marijuana Business Daily (MJBizDaily), the US-based business news and information resource, where he focussed on how cannabis markets and investments were evolving internationally.

 

Mr. Alfredo Pascual commented, "This is an important time to join the team at FastForward and I am keen to align my experience in the flourishing European medical cannabis sector with their position in the UK as the only quoted investment fund with a significant exposure to the space .

 

"After spending recent years analysing the complex European cannabis industry, I am excited to now work with FastForward to find and assess companies which are well positioned to capitalise on the opportunities being presented in the sector, and which are potential investment opportunities for FastForward."

 

Ed McDermott, Chief Executive Officer of FastForward, commented, "I am delighted to welcome Alfredo to our team; his experience and sector knowledge will be invaluable to FFWDs shareholders as our investment focus increasingly leans towards health, wellness and medical cannabis.  Alfredo is based in Germany which is home to the largest medical cannabis market in Europe. In this regard, we are extremely ambitious and with liquid assets valued at north of £12 million, we look forward to delivering more investment news shortly."

 

**ENDS**

 

For further information on the Company please visit www.fstfwd.co   or contact:

Ed McDermott

Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co  

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

 

Tel: (0)20 7186 9927

Catherine Leftley

Megan Dennison

St Brides Partners Ltd,

Financial PR

E: info@stbridespartners.co.uk

 

Notes

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXLAFLAFEEA
UK 100

Latest directors dealings